Skip to main content
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,762.70
-15.55 (-0.87%)
Jan 21, 2025, 3:29 PM IST

NSE: SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 132.91B INR in the quarter ending September 30, 2024, with 9.01% growth. This brings the company's revenue in the last twelve months to 503.08B, up 8.64% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharmaceutical Industries had annual revenue of 484.97B with 10.51% growth.

Revenue (ttm)
503.08B
Revenue Growth
+8.64%
P/S Ratio
8.40
Revenue / Employee
11.70M
Employees
43,000
Market Cap
4,229.31B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020328.38B37.72B12.98%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Divi's Laboratories 86.14B
Cipla 262.64B
Mankind Pharma 110.18B
Zydus Lifesciences 214.84B
Apollo Hospitals Enterprise 204.69B
Aurobindo Pharma 302.95B
Alkem Laboratories 128.32B
Fortis Healthcare 73.13B
Revenue Rankings

Sun Pharmaceutical Industries News

More News